Caxton Associates (New York)’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,126	Closed	-$178K	–	293
2020 Q2	$178K	Buy	+13,126	New	+$178K	0.02%	373
2017 Q4	–	Sell	-12,500	Closed	-$246K	–	288
2017 Q3	$246K	Buy	+12,500	New	+$246K	0.01%	412